Standout Papers

Engineered exosomes as an in situ DC-primed vaccine to boost antitumor i... 2020 2026 2022 2024355
  1. Engineered exosomes as an in situ DC-primed vaccine to boost antitumor immunity in breast cancer (2022)
    Lanxiang Huang, Yuan Rong et al. Molecular Cancer
  2. PD-L1 on dendritic cells attenuates T cell activation and regulates response to immune checkpoint blockade (2020)
    Peng Qi, Xiangyan Qiu et al. Nature Communications

Immediate Impact

4 from Science/Nature 54 standout
Sub-graph 1 of 21

Citing Papers

Recent Advances in 3D Printing of Smart Scaffolds for Bone Tissue Engineering and Regeneration
2024 Standout
Ultrasound-Based Micro-/Nanosystems for Biomedical Applications
2024 Standout
3 intermediate papers

Works of Peng Qi being referenced

Engineered exosomes as an in situ DC-primed vaccine to boost antitumor immunity in breast cancer
2022 Standout
PD-L1 on dendritic cells attenuates T cell activation and regulates response to immune checkpoint blockade
2020 Standout

Author Peers

Author Last Decade Papers Cites
Peng Qi 266 18 9 404 300 12 685
Houhui Shi 260 3 474 393 10 799
Ruoyu Ma 326 344 342 10 750
Xiaonan Xiang 259 4 377 265 7 620
Morgan A. Giese 237 3 1 442 256 12 757
Tristan Courau 197 454 363 14 761
Je Lin Sieow 203 1 362 290 9 609
Xiuqi Wu 289 37 348 533 12 781
Sabina Kaczanowska 311 4 506 351 10 844
Priyamvada Jayaprakash 292 3 289 222 14 662
Hualing Zhang 245 3 327 349 7 674

All Works

Loading papers...

Rankless by CCL
2026